logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: global-slide-stainer-market
Load new posts () and activity
Like Reblog Comment
text 2019-10-25 11:31
Latest Research Report on Slide Stainer Market with its Key Opportunities and Business Challenges

The slide stainers market was valued at USD 2.52 billion in 2017 and is expected to reach USD 4.70 billion in 2023, at a CAGR of 11.0% during the forecast period.

 

The major factors driving the growth of Slide Stainer market include the increasing incidence of chronic diseases, rising geriatric population, growing automation in laboratories, and increasing healthcare expenditure.

 

The reagents segment accounted for the largest share of the global slide stainers market in 2017. The large share of this segment is attributed to the rising prevalence of chronic and infectious diseases, increasing healthcare expenditure, increasing public awareness, and growing demand for automation in diagnostics and clinical research.

 

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134046412

 

The slide stainers market is segmented into hematoxylin and eosin (H&E), immunohistochemistry, in situ hybridization, cytology, microbiology, hematology, and special stains. In 2017, the H&E segment accounted for the largest share of the slide stainers market. The large share of this segment can be attributed to the fact that H&E staining is the initial staining technique for various diseases and is associated with better quality, ease of use, and higher throughput than most other staining technologies.

 

Geographically, the global slide stainers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2017, North America accounted for the largest share of the slide stainers market, followed by Europe and Asia Pacific. Factors such as the highly developed healthcare system in this region, the easy accessibility to technologically advanced instruments, and the presence of major key players in the region are responsible for the large share of the North American slide stainers market.

 

Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=134046412

 

The prominent players in the global slide stainers market are Roche (Switzerland), Agilent (US), Danaher (US), BioGenex (US), Thermo Fisher Scientific (US), Sakura (Japan), Biocare Medical (US), Merck Group (Germany), General Data Company (US), and Hardy Diagnostics (US).

Like Reblog Comment
text 2019-10-03 11:48
Slide Stainer: An Emerging Market with Attractive Growth Opportunities

According to the new market research “Slide Stainer Market by Product (Reagent, Equipment (Automated, Manual)), Technology (Hematoxylin & Eosin, Immunohistochemistry, In Situ Hybridization, Microbiology, Special Stains), End User (Hospital, Pharmaceutical, Academic) - Global Forecast to 2023", analyzes and studies the major market drivers, restraints/challenges, and opportunities. The slide stainers market was valued at USD 2.52 billion in 2017 and is expected to reach USD 4.70 billion in 2023, at a CAGR of 11.0% during the forecast period.

The global Slide Stainer market is segmented based on product, technology, and end user.

 

On the basis of product, the reagents segment accounted for the largest share of the global slide stainers market in 2017. The large share of this segment is attributed to the rising prevalence of chronic and infectious diseases, increasing healthcare expenditure, increasing public awareness, and growing demand for automation in diagnostics and clinical research.

 

Download a PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134046412

 

Browse and in-depth TOC on in “Slide Stainer Market " 
104 - Tables
30 - Figures 
140 - Pages 

Based on technology, the slide stainers market is segmented into hematoxylin and eosin (H&E), immunohistochemistry, in situ hybridization, cytology, microbiology, hematology, and special stains. In 2017, the H&E segment accounted for the largest share of the slide stainers market. The large share of this segment can be attributed to the fact that H&E staining is the initial staining technique for various diseases and is associated with better quality, ease of use, and higher throughput than most other staining technologies.

 

On the basis of end user, the slide stainers market is segmented into hospitals and diagnostic centers, academic and research institutes, pharmaceutical and biotechnology companies and other end users (contract research organizations and forensics, food, & environmental laboratories). The hospitals and diagnostic centers segment accounted for the largest share in 2017. Factors such as the growing prevalence of diseases and huge patient inflow in hospitals and diagnostic centers are driving the growth of this end-user segment.

 

Request Free Sample Report @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=134046412

 

North America accounted for the largest share of the slide stainers market in 2017, followed by Europe and Asia Pacific. The highly developed healthcare system in this region, the easy accessibility to technologically advanced instruments, and the presence of major key players in the region are the major factors responsible for the large share of the North American slide stainers market.

 

Market Players

The key players in the Slide Stainer market are Roche (Switzerland), Agilent (US), Danaher (US), BioGenex (US), Thermo Fisher Scientific (US), Sakura (Japan), Biocare Medical (US), Merck Group (Germany), General Data Company (US), and Hardy Diagnostics (US).

View Complete Press Release @ 
https://www.marketsandmarkets.com/PressReleases/slide-stainer.asp

Like Reblog Comment
text 2019-08-06 12:12
Latest Research Report on Slide Stainer Market Growth, Industry Revenue Analysis

<!-- wp:paragraph -->

The major factors driving the growth of this market include the increasing incidence of chronic diseases, rising geriatric population, growing automation in laboratories, and increasing healthcare expenditure.

<!-- /wp:paragraph --> <!-- wp:paragraph -->

 

The Slide Stainer market was valued at USD 2.52 billion in 2017 and is expected to reach USD 4.70 billion in 2023, at a CAGR of 11.0% during the forecast period.

<!-- /wp:paragraph --> <!-- wp:paragraph -->

 

+ Market Dynamics 

<!-- /wp:paragraph --> <!-- wp:paragraph -->

 

+ Drivers

<!-- /wp:paragraph --> <!-- wp:paragraph -->

+ Increasing Incidence of Chronic Diseases
+ Rising Geriatric Population
+ Increasing Automation in Laboratories
+ Increasing Healthcare Expenditure

<!-- /wp:paragraph --> <!-- wp:paragraph -->

 

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134046412

<!-- /wp:paragraph --> <!-- wp:paragraph -->

 

The reagents segment accounted for the largest share of the global slide stainers market in 2017. The large share of this segment is attributed to the rising prevalence of chronic and infectious diseases, increasing healthcare expenditure, increasing public awareness, and growing demand for automation in diagnostics and clinical research.

<!-- /wp:paragraph --> <!-- wp:paragraph -->

 

The slide stainers market is segmented into hematoxylin and eosin (H&E), immunohistochemistry, in situ hybridization, cytology, microbiology, hematology, and special stains. In 2017, the H&E segment accounted for the largest share of the slide stainers market. The large share of this segment can be attributed to the fact that H&E staining is the initial staining technique for various diseases and is associated with better quality, ease of use, and higher throughput than most other staining technologies.

View complete press release:-
https://www.marketsandmarkets.com/PressReleases/slide-stainer.asp

<!-- /wp:paragraph -->

More posts
Your Dashboard view:
Need help?